Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes,Gene_set
Malaria_Homo sapiens_hsa05144,3/49,0.0027457885257051963,0.8045160380316224,0,0,10.741138560687432,63.34787310808364,GYPA;HBB;HBA2,KEGG_2016
Thyroid cancer_Homo sapiens_hsa05216,2/29,0.011826372804514065,1.0,0,0,12.099213551119174,53.68933161448836,RXRA;MAP2K2,KEGG_2016
Gap junction_Homo sapiens_hsa04540,3/88,0.013935477337664731,1.0,0,0,5.980861244019137,25.558118206030308,MAP3K2;TJP1;MAP2K2,KEGG_2016
African trypanosomiasis_Homo sapiens_hsa05143,2/35,0.01695202737300832,1.0,0,0,10.025062656641603,40.875868103069955,HBB;HBA2,KEGG_2016
Transcriptional misregulation in cancer_Homo sapiens_hsa05202,4/180,0.019692338010149992,1.0,0,0,3.8986354775828462,15.311990847514105,RXRA;BCL6;JMJD1C;ETV6,KEGG_2016
FoxO signaling pathway_Homo sapiens_hsa04068,3/133,0.040553081080532856,1.0,0,0,3.9572615749901066,12.683591290264886,MAP2K2;BCL6;AGAP2,KEGG_2016
Non-small cell lung cancer_Homo sapiens_hsa05223,2/56,0.040621658514130535,1.0,0,0,6.265664160401004,20.071766251096346,MAP2K2;RXRA,KEGG_2016
Apoptosis_Homo sapiens_hsa04210,3/140,0.046036800411654887,1.0,0,0,3.7593984962406015,11.572609749551173,SPTA1;MAP2K2;PARP1,KEGG_2016
Central carbon metabolism in cancer_Homo sapiens_hsa05230,2/67,0.056030450040435435,1.0,0,0,5.2369730295888965,15.092223018087369,MAP2K2;SIRT6,KEGG_2016
Bile secretion_Homo sapiens_hsa04976,2/71,0.06206634825645156,1.0,0,0,4.94193229552755,13.736354499396091,RXRA;AQP4,KEGG_2016
Chronic myeloid leukemia_Homo sapiens_hsa05220,2/73,0.0651638680782169,1.0,0,0,4.806536890170632,13.125931911743779,BCR;MAP2K2,KEGG_2016
Fatty acid biosynthesis_Homo sapiens_hsa00061,1/13,0.071638483872761,1.0,0,0,13.495276653171391,35.575207356977394,FASN,KEGG_2016
GnRH signaling pathway_Homo sapiens_hsa04912,2/91,0.09515594563857586,1.0,0,0,3.85579332947754,9.06974436162207,MAP3K2;MAP2K2,KEGG_2016
Longevity regulating pathway - mammal_Homo sapiens_hsa04211,2/94,0.1004816478455976,1.0,0,0,3.732736095558044,8.577007005074599,SESN1;ULK2,KEGG_2016
Viral carcinogenesis_Homo sapiens_hsa05203,3/205,0.11232930687048172,1.0,0,0,2.5673940949935816,5.613146294796518,HDAC4;CHD4;HLA-A,KEGG_2016
Collecting duct acid secretion_Homo sapiens_hsa04966,1/27,0.14310556894732926,1.0,0,0,6.4977257959714105,12.632700953240144,SLC4A1,KEGG_2016
Dorso-ventral axis formation_Homo sapiens_hsa04320,1/27,0.14310556894732926,1.0,0,0,6.4977257959714105,12.632700953240144,ETV6,KEGG_2016
Thyroid hormone signaling pathway_Homo sapiens_hsa04919,2/118,0.14567443389578744,1.0,0,0,2.973535533749628,5.728162509774536,RXRA;MAP2K2,KEGG_2016
Vascular smooth muscle contraction_Homo sapiens_hsa04270,2/120,0.14961221067767025,1.0,0,0,2.9239766081871346,5.554703492969967,MAP2K2;MYLK,KEGG_2016
Base excision repair_Homo sapiens_hsa03410,1/33,0.1720389388421968,1.0,0,0,5.31632110579479,9.356908235902694,PARP1,KEGG_2016
Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650,2/135,0.17976373233738152,1.0,0,0,2.599090318388564,4.460329794487533,MAP2K2;HLA-A,KEGG_2016
Prion diseases_Homo sapiens_hsa05020,1/35,0.18146652701967614,1.0,0,0,5.012531328320802,8.554807350473528,MAP2K2,KEGG_2016
Endocytosis_Homo sapiens_hsa04144,3/259,0.1839856505880366,1.0,0,0,2.03210729526519,3.440149380916066,AGAP2;HLA-A;EPS15L1,KEGG_2016
Insulin signaling pathway_Homo sapiens_hsa04910,2/139,0.18795783775610247,1.0,0,0,2.524296352391771,4.219456288170197,MAP2K2;FASN,KEGG_2016
Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550,2/142,0.19413756189302048,1.0,0,0,2.470966147763776,4.050378772611396,ZFHX3;MAP2K2,KEGG_2016
Allograft rejection_Homo sapiens_hsa05330,1/38,0.1954087513192556,1.0,0,0,4.616805170821792,7.53768122662141,HLA-A,KEGG_2016
Regulation of autophagy_Homo sapiens_hsa04140,1/39,0.20000364514190735,1.0,0,0,4.49842555105713,7.239854641883263,ULK2,KEGG_2016
"Glycine, serine and threonine metabolism_Homo sapiens_hsa00260",1/40,0.20457252711779186,1.0,0,0,4.385964912280701,6.959792590096806,BPGM,KEGG_2016
Graft-versus-host disease_Homo sapiens_hsa05332,1/41,0.209115543229536,1.0,0,0,4.278990158322636,6.696056231738787,HLA-A,KEGG_2016
Bladder cancer_Homo sapiens_hsa05219,1/41,0.209115543229536,1.0,0,0,4.278990158322636,6.696056231738787,MAP2K2,KEGG_2016
Type I diabetes mellitus_Homo sapiens_hsa04940,1/43,0.2181245575317232,1.0,0,0,4.079967360261119,6.212521479132445,HLA-A,KEGG_2016
Phagosome_Homo sapiens_hsa04145,2/154,0.219092634858782,1.0,0,0,2.2784233310549102,3.459240483887064,NCF1;HLA-A,KEGG_2016
Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962,1/44,0.22259084363141607,1.0,0,0,3.9872408293460926,5.990510266020702,AQP4,KEGG_2016
Oxytocin signaling pathway_Homo sapiens_hsa04921,2/158,0.2274760384859474,1.0,0,0,2.220741727737064,3.2882753086269814,MAP2K2;MYLK,KEGG_2016
MicroRNAs in cancer_Homo sapiens_hsa05206,3/297,0.2400440704821064,1.0,0,0,1.7721070352649302,2.5286775571305067,HDAC4;MAP2K2;DICER1,KEGG_2016
Fatty acid metabolism_Homo sapiens_hsa01212,1/48,0.24020450214852124,1.0,0,0,3.6549707602339176,5.212955505040863,FASN,KEGG_2016
cGMP-PKG signaling pathway_Homo sapiens_hsa04022,2/167,0.2464153031977399,1.0,0,0,2.101061035823091,2.9430338105213907,MAP2K2;MYLK,KEGG_2016
Vibrio cholerae infection_Homo sapiens_hsa05110,1/51,0.2531546163284746,1.0,0,0,3.439972480220158,4.725678862010546,TJP1,KEGG_2016
Endometrial cancer_Homo sapiens_hsa05213,1/52,0.2574225118574089,1.0,0,0,3.373819163292848,4.5783958467979184,MAP2K2,KEGG_2016
Autoimmune thyroid disease_Homo sapiens_hsa05320,1/53,0.26166623087870555,1.0,0,0,3.3101621979476987,4.437886512085148,HLA-A,KEGG_2016
Acute myeloid leukemia_Homo sapiens_hsa05221,1/57,0.278402046118184,1.0,0,0,3.077870113881194,3.9356386610847593,MAP2K2,KEGG_2016
Viral myocarditis_Homo sapiens_hsa05416,1/59,0.2866283887292272,1.0,0,0,2.973535533749628,3.715636975935329,HLA-A,KEGG_2016
Glycerolipid metabolism_Homo sapiens_hsa00561,1/59,0.2866283887292272,1.0,0,0,2.973535533749628,3.715636975935329,LPIN2,KEGG_2016
Long-term depression_Homo sapiens_hsa04730,1/60,0.2907066314543067,1.0,0,0,2.9239766081871346,3.612399589640872,MAP2K2,KEGG_2016
mTOR signaling pathway_Homo sapiens_hsa04150,1/60,0.2907066314543067,1.0,0,0,2.9239766081871346,3.612399589640872,ULK2,KEGG_2016
VEGF signaling pathway_Homo sapiens_hsa04370,1/61,0.29476176282840394,1.0,0,0,2.8760425654299686,3.513338603814153,MAP2K2,KEGG_2016
Glioma_Homo sapiens_hsa05214,1/65,0.31075375969871377,1.0,0,0,2.699055330634278,3.15453292813874,MAP2K2,KEGG_2016
Long-term potentiation_Homo sapiens_hsa04720,1/66,0.314695266907252,1.0,0,0,2.658160552897395,3.073233692291243,MAP2K2,KEGG_2016
Renal cell carcinoma_Homo sapiens_hsa05211,1/66,0.314695266907252,1.0,0,0,2.658160552897395,3.073233692291243,MAP2K2,KEGG_2016
Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010,1/67,0.3186144308801277,1.0,0,0,2.6184865147944487,2.9949557158088624,BPGM,KEGG_2016
Epstein-Barr virus infection_Homo sapiens_hsa05169,2/202,0.3201648797317597,1.0,0,0,1.7370158068438422,1.9783205953133336,HDAC4;HLA-A,KEGG_2016
Proteoglycans in cancer_Homo sapiens_hsa05205,2/203,0.3222568516887643,1.0,0,0,1.728459078731311,1.9573180803044248,MAP2K2;ANK1,KEGG_2016
Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120,1/68,0.32251137711037503,1.0,0,0,2.5799793601651184,2.9195481566226285,TJP1,KEGG_2016
Fc epsilon RI signaling pathway_Homo sapiens_hsa04664,1/68,0.32251137711037503,1.0,0,0,2.5799793601651184,2.9195481566226285,MAP2K2,KEGG_2016
PPAR signaling pathway_Homo sapiens_hsa03320,1/69,0.3263862305119028,1.0,0,0,2.5425883549453343,2.8468696738207653,RXRA,KEGG_2016
p53 signaling pathway_Homo sapiens_hsa04115,1/69,0.3263862305119028,1.0,0,0,2.5425883549453343,2.8468696738207653,SESN1,KEGG_2016
Adipocytokine signaling pathway_Homo sapiens_hsa04920,1/70,0.3302391151786854,1.0,0,0,2.506265664160401,2.776787707921533,RXRA,KEGG_2016
Inositol phosphate metabolism_Homo sapiens_hsa00562,1/71,0.33407015460128986,1.0,0,0,2.470966147763776,2.70917782146057,SYNJ2,KEGG_2016
Melanoma_Homo sapiens_hsa05218,1/71,0.33407015460128986,1.0,0,0,2.470966147763776,2.70917782146057,MAP2K2,KEGG_2016
Prolactin signaling pathway_Homo sapiens_hsa04917,1/72,0.3378794715200135,1.0,0,0,2.4366471734892787,2.643923099974717,MAP2K2,KEGG_2016
Leishmaniasis_Homo sapiens_hsa05140,1/73,0.341667188006915,1.0,0,0,2.403268445085316,2.5809136029920805,NCF1,KEGG_2016
B cell receptor signaling pathway_Homo sapiens_hsa04662,1/73,0.341667188006915,1.0,0,0,2.403268445085316,2.5809136029920805,MAP2K2,KEGG_2016
Regulation of actin cytoskeleton_Homo sapiens_hsa04810,2/214,0.3451563341954169,1.0,0,0,1.6396130513198883,1.7441512083841064,MAP2K2;MYLK,KEGG_2016
Gastric acid secretion_Homo sapiens_hsa04971,1/74,0.3454334255175197,1.0,0,0,2.3707918444760554,2.5200458620075,MYLK,KEGG_2016
Adherens junction_Homo sapiens_hsa04520,1/74,0.3454334255175197,1.0,0,0,2.3707918444760554,2.5200458620075,TJP1,KEGG_2016
RNA degradation_Homo sapiens_hsa03018,1/77,0.3566044680114481,1.0,0,0,2.2784233310549102,2.349346193107156,EDC4,KEGG_2016
Antigen processing and presentation_Homo sapiens_hsa04612,1/77,0.3566044680114481,1.0,0,0,2.2784233310549102,2.349346193107156,HLA-A,KEGG_2016
Insulin secretion_Homo sapiens_hsa04911,1/85,0.3854784764395836,1.0,0,0,2.063983488132094,1.9675333753952755,PCLO,KEGG_2016
Small cell lung cancer_Homo sapiens_hsa05222,1/86,0.3889961930766683,1.0,0,0,2.0399836801305593,1.9261234635799227,RXRA,KEGG_2016
Salmonella infection_Homo sapiens_hsa05132,1/86,0.3889961930766683,1.0,0,0,2.0399836801305593,1.9261234635799227,TJP1,KEGG_2016
ErbB signaling pathway_Homo sapiens_hsa04012,1/87,0.39249394876235777,1.0,0,0,2.016535591853196,1.885932968430101,MAP2K2,KEGG_2016
Pathways in cancer_Homo sapiens_hsa05200,3/397,0.3949830933679444,1.0,0,0,1.3257324671881214,1.2314892172838003,BCR;RXRA;MAP2K2,KEGG_2016
Hematopoietic cell lineage_Homo sapiens_hsa04640,1/88,0.3959718557647208,1.0,0,0,1.9936204146730463,1.8469141578041293,GYPA,KEGG_2016
Prostate cancer_Homo sapiens_hsa05215,1/89,0.3994300257726861,1.0,0,0,1.9712201852946971,1.8090216511503543,MAP2K2,KEGG_2016
Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666,1/93,0.4130675466023897,1.0,0,0,1.8864365214110543,1.6678818115426377,NCF1,KEGG_2016
NF-kappa B signaling pathway_Homo sapiens_hsa04064,1/93,0.4130675466023897,1.0,0,0,1.8864365214110543,1.6678818115426377,PARP1,KEGG_2016
Glycerophospholipid metabolism_Homo sapiens_hsa00564,1/95,0.419770742205874,1.0,0,0,1.8467220683287164,1.6030407546202732,LPIN2,KEGG_2016
MAPK signaling pathway_Homo sapiens_hsa04010,2/255,0.4279105583831944,1.0,0,0,1.3759889920880632,1.1679959834592542,MAP3K2;MAP2K2,KEGG_2016
Phosphatidylinositol signaling system_Homo sapiens_hsa04070,1/98,0.4296835053146595,1.0,0,0,1.7901897601145718,1.512184703638754,SYNJ2,KEGG_2016
Estrogen signaling pathway_Homo sapiens_hsa04915,1/99,0.43295031021429786,1.0,0,0,1.7721070352649302,1.4834880641070287,MAP2K2,KEGG_2016
Melanogenesis_Homo sapiens_hsa04916,1/100,0.4361985658337181,1.0,0,0,1.7543859649122806,1.4555398475158332,MAP2K2,KEGG_2016
Choline metabolism in cancer_Homo sapiens_hsa05231,1/101,0.4394283765814493,1.0,0,0,1.7370158068438422,1.428314297068334,MAP2K2,KEGG_2016
HIF-1 signaling pathway_Homo sapiens_hsa04066,1/103,0.4458330781063956,1.0,0,0,1.7032873445750296,1.3759336762934509,MAP2K2,KEGG_2016
T cell receptor signaling pathway_Homo sapiens_hsa04660,1/104,0.4490081747323911,1.0,0,0,1.6869095816464237,1.3507324306253066,MAP2K2,KEGG_2016
Toll-like receptor signaling pathway_Homo sapiens_hsa04620,1/106,0.4553043704329457,1.0,0,0,1.6550810989738496,1.3021998306344924,MAP2K2,KEGG_2016
Leukocyte transendothelial migration_Homo sapiens_hsa04670,1/118,0.4916114818889726,1.0,0,0,1.486767766874814,1.0557040520391772,NCF1,KEGG_2016
Sphingolipid signaling pathway_Homo sapiens_hsa04071,1/120,0.4974249262982606,1.0,0,0,1.4619883040935673,1.0209219819932351,MAP2K2,KEGG_2016
Neurotrophin signaling pathway_Homo sapiens_hsa04722,1/120,0.4974249262982606,1.0,0,0,1.4619883040935673,1.0209219819932351,MAP2K2,KEGG_2016
Platelet activation_Homo sapiens_hsa04611,1/122,0.5031724700337536,1.0,0,0,1.4380212827149843,0.9876650631037952,MYLK,KEGG_2016
AMPK signaling pathway_Homo sapiens_hsa04152,1/124,0.5088548536324593,1.0,0,0,1.4148273910582907,0.9558467217813544,FASN,KEGG_2016
Osteoclast differentiation_Homo sapiens_hsa04380,1/132,0.5309473096424226,1.0,0,0,1.3290802764486975,0.8414307432336782,NCF1,KEGG_2016
Hepatitis C_Homo sapiens_hsa05160,1/133,0.533638666076197,1.0,0,0,1.3190871916633689,0.8284346713421398,RXRA,KEGG_2016
Tight junction_Homo sapiens_hsa04530,1/139,0.5494683409194208,1.0,0,0,1.2621481761958857,0.7557795293949191,TJP1,KEGG_2016
Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514,1/142,0.5571822706818687,1.0,0,0,1.2354830738818878,0.7225881593431179,HLA-A,KEGG_2016
Phospholipase D signaling pathway_Homo sapiens_hsa04072,1/144,0.5622520103440035,1.0,0,0,1.2183235867446394,0.7015169500671087,MAP2K2,KEGG_2016
Hepatitis B_Homo sapiens_hsa05161,1/146,0.5672642106137394,1.0,0,0,1.201634222542658,0.6812426146009373,MAP2K2,KEGG_2016
Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932,1/151,0.5795472068138459,1.0,0,0,1.1618450098756825,0.6337959314935766,RXRA,KEGG_2016
PI3K-Akt signaling pathway_Homo sapiens_hsa04151,2/341,0.5815417895884573,1.0,0,0,1.028965375315121,0.5577737762506315,RXRA;MAP2K2,KEGG_2016
Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141,1/169,0.6209722404033148,1.0,0,0,1.0380982040901068,0.4946215088671598,DNAJA2,KEGG_2016
Influenza A_Homo sapiens_hsa05164,1/175,0.6338605687195926,1.0,0,0,1.0025062656641603,0.4570689442473895,MAP2K2,KEGG_2016
Alcoholism_Homo sapiens_hsa05034,1/179,0.6422104709159115,1.0,0,0,0.9801038910124472,0.4340284158591985,HDAC4,KEGG_2016
Calcium signaling pathway_Homo sapiens_hsa04020,1/180,0.6442682811381469,1.0,0,0,0.9746588693957116,0.42849907797976655,MYLK,KEGG_2016
Herpes simplex infection_Homo sapiens_hsa05168,1/185,0.6543826690449992,1.0,0,0,0.948316737790422,0.4021460197036434,HLA-A,KEGG_2016
Chemokine signaling pathway_Homo sapiens_hsa04062,1/187,0.6583481368859274,1.0,0,0,0.9381743127873158,0.392176943577105,NCF1,KEGG_2016
cAMP signaling pathway_Homo sapiens_hsa04024,1/199,0.6812113654867491,1.0,0,0,0.8816009873931059,0.3384313196023417,MAP2K2,KEGG_2016
Focal adhesion_Homo sapiens_hsa04510,1/202,0.6866860486906912,1.0,0,0,0.8685079034219211,0.3264530832172952,MYLK,KEGG_2016
Rap1 signaling pathway_Homo sapiens_hsa04015,1/211,0.7025571116865456,1.0,0,0,0.8314625426124553,0.2935300434890489,MAP2K2,KEGG_2016
Ras signaling pathway_Homo sapiens_hsa04014,1/227,0.7288292736513953,1.0,0,0,0.772857253265322,0.2444669347885628,MAP2K2,KEGG_2016
HTLV-I infection_Homo sapiens_hsa05166,1/258,0.7733589717939513,1.0,0,0,0.6799945600435197,0.17476672810935134,HLA-A,KEGG_2016
Metabolic pathways_Homo sapiens_hsa01100,4/1239,0.9283482588202652,1.0,0,0,0.5663877207142148,0.042109985525567065,FASN;SYNJ2;BPGM;LPIN2,KEGG_2016
